Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Omthera Pharmaceuticals

A company developing therapies to treat dyslipidemia and cardiovascular disease

Overview Structured Data Issues Contributors Activity

omthera.com

Is a

Company

Organization

Company attributes

Industry

Location

Princeton, New Jersey

AngelList URL

angel.co/omthera-ph...maceuticals

Pitchbook URL

pitchbook.com/profiles.../51676-75

CIK Number

1,477,5980

Place of Incorporation

Delaware

Investors

Sofinnova Partners

NEA (New Enterprise Associates)

IRS Number

263,797,7380

Total Funding Amount (USD)

40,400,000

Latest Funding Round Date

March 14, 2011

Stock Symbol

OMTH

Exchange

New York Stock Exchange

Latest Funding Type

Series B Round

Patents Assigned (Count)

Wellfound ID

omthera-pharmaceuticals

Headquarters

New Jersey

Other attributes

Company Operating Status

Closed

SIC Code

2,8340

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Omthera Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.